Strs Ohio Relmada Therapeutics, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$16.5 - $30.34 $100,650 - $185,074	-6,100 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$21.86 - $34.77 $19,674 - $31,293	900 Added 17.31%	6,100 $159,000
Q2 2021 Jul 26, 2021	BUY	$29.55 - $39.15 $153,660 - $203,580	5,200 New	5,200 $166,000
Q3 2020 Dec 14, 2020	SELL	$34.42 - $43.78 $123,912 - $157,608	-3,600 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$31.59 - $49.98 $113,724 - $179,928	3,600 New	3,600 $161,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.